Clopidogrel is an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent (dual antiplatelet therapy).


Machine Learning
For each new compound we screen, a standardized cell based profile is created. This profile, or feature rich biological fingerprint, encodes the specific toxin effect of each unique compound on critical indicators of cellular stress.
Biological Fingerprint
Each new compound fingerprint is then compared to a database containing fingerprints from a carefully selected training set of marketed therapeutics, failed and withdrawn drugs and known toxins.
Our Services
AsedaServices® provides multi-parametric, high content, high throughput phenotypic screening services to the bio-pharmaceutical industry.
Unique Platform
Our unique Platform utilizes the inherent strength of flow cytometry, automated processes and sophisticated data analysis to deliver high value information.

Faster Results

Earlier identification of potential toxicity delivers the greatest financial benefits for the chemical producing industries by reducing the massive costs of downstream failures that occur at all phases of development.

  • AsedaSciences can help predict the hidden safety risks and accelerate informed decisions making on weather to Approve, Improve or Remove™ a compound from the R&D pipeline.
  • 25-30% of potential therapeutic compounds entering Phase II and Phase III clinical trials fail due patient safety concerns, ultimately costing the pharmaceutical industry billions of dollars.
  • By predicting risk of compound toxicity at the start of Drug Discovery, chemist can design safer drugs that will assist in improving the quality of the drug discovery pipeline.  This in turn will help reduce the financial burden of later stage failures, reduce and refine the use of animals and minimize the safety risk to patients.